STOK NASDAQ
Stoke Therapeutics, Inc.
1W: +3.3%
1M: -16.0%
3M: -21.0%
YTD: -17.1%
1Y: +8.6%
3Y: +556.9%
5Y: -1.5%
$25.62
-0.39 (-1.50%)
Weekly Expected Move ±7.2%
$22
$24
$26
$27
$29
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$28M
Revenue
-86.2% YoY
$-208M
Net Income
-496.1% YoY
$-181M
Free Cash Flow
-395.5% YoY
87.8%
Gross Margin
-701.7%
Op. Margin
-660.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-61.1%
ROA-53.4%
ROIC-318.5%
Valuation
P/E-7.6
P/B4.9
EV/EBITDA-9.1
Leverage
Debt/Equity0.01
Current Ratio7.69
Interest Cov.-4556.3x
Quality Scores
Piotroski F2/9
Altman Z23.77
Beneish M2.96